MCID: CRN017
MIFTS: 48

Coronary Thrombosis malady

Categories: Cardiovascular diseases, Blood diseases

Aliases & Classifications for Coronary Thrombosis

Aliases & Descriptions for Coronary Thrombosis:

Name: Coronary Thrombosis 12 52 42 14 69
Coronary Artery Thrombosis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:11847
ICD10 33 I21 I22
MeSH 42 D003328
UMLS 69 C0010072

Summaries for Coronary Thrombosis

MalaCards based summary : Coronary Thrombosis, also known as coronary artery thrombosis, is related to myocardial infarction and essential thrombocythemia. An important gene associated with Coronary Thrombosis is PLAT (Plasminogen Activator, Tissue Type), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and ECM-receptor interaction. The drugs Aspirin and Abciximab have been mentioned in the context of this disorder. Affiliated tissues include heart, lung and testes, and related phenotypes are hematopoietic system and homeostasis/metabolism

Wikipedia : 71 Coronary thrombosis is the formation of a blood clot inside a blood vessel of the heart. This blood clot... more...

Related Diseases for Coronary Thrombosis

Diseases related to Coronary Thrombosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 155)
id Related Disease Score Top Affiliating Genes
1 myocardial infarction 28.9 F3 GP1BA GP6 ITGB3 P2RY12 PLAT
2 essential thrombocythemia 28.9 F3 GP1BA ITGB3 SERPINC1 VWF
3 thrombosis 10.8
4 peanut allergy 10.3 PLAT SERPINC1
5 melorheostosis 10.3 PLAT SERPINC1
6 fanconi-bickel syndrome 10.3 PLAT SERPINC1
7 silent myocardial infarction 10.3 PLAT SERPINC1
8 fetal macrosomia 10.2 GP1BA ITGB3
9 facial dysmorphism-anorexia-cachexia-eye and skin anomalies syndrome 10.2 GP1BA ITGB3
10 eagle syndrome 10.2 PLAT SERPINC1
11 enamel hypoplasia cataract hydrocephaly 10.2 PLAT VWF
12 acute myocardial infarction 10.2
13 trismus-pseudocamptodactyly syndrome 10.2 GP1BA VWF
14 vcl-related dilated cardiomyopathy 10.2 GP1BA VWF
15 acromegaloid hypertrichosis syndrome 10.2 GP1BA VWF
16 inflammatory bowel disease 11 10.2 PLAT SERPINE1
17 cerebral calcifications opalescent teeth phosphaturia 10.2 PLAT SERPINE1
18 villous adenoma 10.2 GP1BA ITGB3
19 chronic fatigue syndrome 10.2 PLAT SERPINE1
20 sezary's disease 10.1 PLAT SERPINE1
21 lymphocytic colitis 10.1 SERPINC1 SERPINE1
22 cytogenetically normal acute myeloid leukemia 10.1 ITGB3 P2RY12
23 bullous skin disease 10.1 SERPINC1 SERPINE1
24 gluten allergy 10.1 ITGB3 VWF
25 neuroaxonal dystrophy 10.1 SERPINC1 SERPINE1
26 periosteal chondrosarcoma 10.1 SERPINC1 SERPINE1
27 alpha-2-plasmin inhibitor deficiency 10.1 GP1BA SERPINC1
28 czech dysplasia 10.1 SERPINC1 SERPINE1
29 mental retardation hypotonia skin hyperpigmentation 10.1 SERPINC1 SERPINE1
30 perrault syndrome 10.1 PLAT SERPINE1
31 dysgammaglobulinemia 10.1 SERPINC1 SERPINE1
32 sertoli cell tumor 10.1 F3 SERPINC1
33 influenza 10.1 F3 SERPINC1
34 freiberg's disease 10.1 F3 SERPINC1
35 hereditary endotheliopathy, retinopathy, nephropathy, and stroke 10.1 F3 SERPINC1
36 pancreatic ductal carcinoma 10.1 F3 SERPINC1
37 chorioretinal scar 10.1 F3 SERPINC1
38 mixed hepatoblastoma 10.1 F3 SERPINC1
39 dmd-related dilated cardiomyopathy 10.1 F3 SERPINC1
40 spinal cord lipoma 10.1 F3 SERPINC1
41 cetp-related hyperalphalipoproteinemia 10.1 SERPINE1 VWF
42 neuronopathy, distal hereditary motor, type iid 10.1 F3 SERPINC1
43 severe nonproliferative diabetic retinopathy 10.1 GP1BA ITGB3 VWF
44 immunodeficiency 20 10.1 GP1BA GP6 ITGB3
45 brazilian hemorrhagic fever 10.0 PLAT SERPINC1 SERPINE1
46 lynch syndrome 10.0 PLAT SERPINC1 SERPINE1
47 conjunctivochalasis 10.0 F3 SERPINC1
48 blepharoconjunctivitis 10.0 F3 SERPINC1
49 intestinal disaccharidase deficiency 10.0 F3 SERPINC1
50 autoimmune disease of central nervous system 10.0 GP1BA ITGB3 SERPINE1

Graphical network of the top 20 diseases related to Coronary Thrombosis:



Diseases related to Coronary Thrombosis

Symptoms & Phenotypes for Coronary Thrombosis

MGI Mouse Phenotypes related to Coronary Thrombosis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.91 F3 GP1BA GP6 ITGB3 P2RY12 PLAT
2 homeostasis/metabolism MP:0005376 9.81 PLAT SERPINC1 SERPINE1 VWF F3 GP1BA
3 cardiovascular system MP:0005385 9.8 F3 ITGB3 PLAT SERPINC1 SERPINE1 VWF
4 immune system MP:0005387 9.5 F3 GP6 ITGB3 PLAT SERPINC1 SERPINE1
5 vision/eye MP:0005391 9.02 F3 GP6 ITGB3 PLAT SERPINC1

Drugs & Therapeutics for Coronary Thrombosis

Drugs for Coronary Thrombosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 559)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
2
Abciximab Approved Phase 4,Phase 3,Phase 2 143653-53-6
3
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
4
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
5
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
6
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2 9005-49-6 772 46507594
7
Nicorandil Approved Phase 4 65141-46-0 47528
8
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 274693-27-5 9871419
9
Salicylic acid Approved, Vet_approved Phase 4,Phase 2 69-72-7 338
10
Warfarin Approved Phase 4,Phase 2,Phase 3,Phase 1 81-81-2 6691 54678486
11
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1 55142-85-3 5472
12
Tirofiban Approved Phase 4,Phase 3 144494-65-5 60947
13
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2 33069-62-4 36314
14
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 73590-58-6 4594
15
Pantoprazole Approved Phase 4,Phase 3,Phase 1 102625-70-7 4679
16
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3 55-56-1 9552079 2713
17
Phenprocoumon Approved Phase 4,Phase 3,Phase 2 435-97-2 9908 54680692
18
Acenocoumarol Approved Phase 4,Phase 3 152-72-7 9052 54676537
19
Rivaroxaban Approved Phase 4,Phase 3,Phase 2,Phase 1 366789-02-8
20
Coal tar Approved Phase 4 8007-45-2
21
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2 128270-60-0 16129704
22
Nitric Oxide Approved Phase 4,Phase 2,Phase 3,Phase 1 10102-43-9 145068
23
Eptifibatide Approved, Investigational Phase 4,Phase 3,Phase 2 188627-80-7 123610
24
Dalteparin Approved Phase 4,Phase 3,Phase 2 9041-08-1
25
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757 53477783
26
Progesterone Approved, Vet_approved Phase 4,Phase 3 57-83-0 5994
27
Tenecteplase Approved Phase 4,Phase 2,Phase 1 191588-94-0
28
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
29
Ezetimibe Approved Phase 4 163222-33-1 150311
30
Simvastatin Approved Phase 4 79902-63-9 54454
31 Edoxaban Approved Phase 4,Phase 3,Phase 2 480449-70-5
32
Adenosine Approved, Investigational Phase 4,Phase 2,Phase 3 58-61-7 60961
33
Verapamil Approved Phase 4 52-53-9 2520
34
Tranexamic Acid Approved Phase 4,Phase 3,Phase 1,Phase 2 1197-18-8 5526
35
Metformin Approved Phase 4,Phase 1 657-24-9 14219 4091
36
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
37
Pravastatin Approved Phase 4 81093-37-0 54687
38
Cilostazol Approved Phase 4 73963-72-1 2754
39
Probucol Approved Phase 4 23288-49-5 4912
40
Fenofibrate Approved Phase 4 49562-28-9 3339
41
Streptokinase Approved Phase 4,Phase 3 9002-01-1
42
Pitavastatin Approved Phase 4 147511-69-1, 147526-32-7 6366718 5282452
43
Diltiazem Approved Phase 4 42399-41-7 39186
44
Acetaminophen Approved Phase 4 103-90-2 1983
45
Indomethacin Approved, Investigational Phase 4 53-86-1 3715
46
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
47
Reteplase Approved Phase 4,Phase 2 133652-38-7 65820
48
Apixaban Approved Phase 4,Phase 3,Phase 2,Phase 1 503612-47-3 10182969
49
Carvedilol Approved, Investigational Phase 4 72956-09-3 2585
50
Abacavir Approved, Investigational Phase 4 136470-78-5 65140 441300

Interventional clinical trials:

(show top 50) (show all 1731)
id Name Status NCT ID Phase
1 Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) Unknown status NCT00963781 Phase 4
2 Monitoring Response to Antiplatelet Therapy Unknown status NCT00327041 Phase 4
3 Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study Unknown status NCT01013038 Phase 4
4 Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction Unknown status NCT01156662 Phase 4
5 Late Incomplete Stent Apposition Evaluation II: Comparison Between Polimer-based and No-polimer Stent System. IVUS Based Study Unknown status NCT01375855 Phase 4
6 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab Unknown status NCT01383785 Phase 4
7 Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI Unknown status NCT01781715 Phase 4
8 Hormones Inflammation and Thrombosis Unknown status NCT01875185 Phase 4
9 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4
10 Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents Unknown status NCT01268371 Phase 4
11 Rosuvastatin for Preventing Deep Vein Thrombosis Unknown status NCT01021488 Phase 4
12 DEDICA (Dose of HEparin During Coronary Angioplasty) Trial Unknown status NCT01694459 Phase 4
13 Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease Unknown status NCT01418794 Phase 4
14 Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis Unknown status NCT02022527 Phase 4
15 Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome Unknown status NCT01951001 Phase 4
16 Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study. Unknown status NCT01914055 Phase 4
17 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Unknown status NCT00698607 Phase 4
18 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry) Unknown status NCT01605721 Phase 4
19 Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease Unknown status NCT02294994 Phase 4
20 Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users Unknown status NCT01063426 Phase 4
21 Safety and Effectiveness of the Coronary Momo Stent Unknown status NCT01535625 Phase 4
22 Intimal Hyperplasia Evaluated by Optical Coherence Tomography (OCT) in de Novo Coronary Lesions Treated by Drug-eluting Balloon and Bare-metal Stent Unknown status NCT01057563 Phase 4
23 Assessment of Surface Coverage of Two Types of DES in Diabetes Mellitus and Non- Diabetes Mellitus Unknown status NCT01023919 Phase 4
24 Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Unknown status NCT01735227 Phase 4
25 A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions Unknown status NCT00825773 Phase 4
26 Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation Unknown status NCT00776633 Phase 4
27 A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Unknown status NCT01942070 Phase 4
28 Anticoagulation in Stent Intervention Unknown status NCT01141153 Phase 4
29 EvaluAtion of Predictive Value of Multisite Intracardiac EchoCardiography During Imaging of Structure and funCTION of Left Atrial Appendage in Comparison to Transesophageal Echocardiography Unknown status NCT01371279 Phase 4
30 Do Cobalt Chrome Stent and Paclitaxel-Eluting Stent Have Equivalent Clinical Result in Non-Complex Lesion? Unknown status NCT00852215 Phase 4
31 Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis Unknown status NCT02402491 Phase 4
32 Paradigm Shift in the Treatment of Patients With ACS Unknown status NCT02041650 Phase 4
33 Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT Unknown status NCT01021930 Phase 4
34 Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Unknown status NCT02334254 Phase 4
35 COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent Unknown status NCT00920283 Phase 4
36 Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions Unknown status NCT01278186 Phase 4
37 MGuard Stent in ST-elevation Myocardial Infarction Unknown status NCT01124942 Phase 4
38 A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment Unknown status NCT01880879 Phase 4
39 Local Thrombolytics Before Thrombectomy in STEMI Unknown status NCT01568931 Phase 4
40 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Unknown status NCT02004730 Phase 4
41 Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting Unknown status NCT00661206 Phase 4
42 Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor Unknown status NCT01869309 Phase 4
43 The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic Patients Unknown status NCT01510509 Phase 4
44 Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI Unknown status NCT00476944 Phase 4
45 Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients Unknown status NCT01198379 Phase 4
46 Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI Unknown status NCT02012140 Phase 4
47 Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction Unknown status NCT00976092 Phase 4
48 Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery Unknown status NCT01648712 Phase 4
49 Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction Unknown status NCT01499407 Phase 4
50 Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL) Unknown status NCT02170103 Phase 4

Search NIH Clinical Center for Coronary Thrombosis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: coronary thrombosis

Genetic Tests for Coronary Thrombosis

Anatomical Context for Coronary Thrombosis

MalaCards organs/tissues related to Coronary Thrombosis:

39
Heart, Lung, Testes, Endothelial, Brain, Adrenal Gland

Publications for Coronary Thrombosis

Articles related to Coronary Thrombosis:

(show top 50) (show all 516)
id Title Authors Year
1
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. ( 27079334 )
2016
2
Coronary thrombosis in diabetes: Are we doing enough? ( 27555606 )
2016
3
Multiple coronary thrombosis. ( 27489604 )
2016
4
Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift? ( 27543999 )
2016
5
Multifocal coronary thrombosis on nondisrupted plaque: observation with optical coherence tomography. ( 27159264 )
2016
6
A rare cause of acute coronary syndrome: Coronary thrombosis in three coronary arteries due to whey protein. ( 27839839 )
2016
7
Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature. ( 26607055 )
2016
8
Coronary Thrombosis without Dissection following Blunt Trauma. ( 27006836 )
2016
9
Endothelial erosion of plaques as a substrate for coronary thrombosis. ( 26791872 )
2016
10
Translation from the data of clinical trials to precision medicine: limitation of the current risk score for predicting coronary thrombosis and major bleeding. ( 27746980 )
2016
11
Evading the fate of Pheidippides: acute coronary thrombosis in a young marathon runner with minimal atherosclerosis but sickle cell trait. ( 26331117 )
2015
12
Simultaneous multi-vessel coronary thrombosis in patients with ST-elevation myocardial infarction: a systematic review. ( 25772369 )
2015
13
Coronary Thrombosis and Type A Aortic Dissection. ( 25980980 )
2015
14
Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment. ( 26761372 )
2015
15
Acute Myocardial Infarction in a Neonate Caused by a Coronary Thrombosis: a Considerable Diagnostic and Therapeutic Challenge. ( 26297178 )
2015
16
Acute ST Elevated Myocardial Injury due to Coronary Thrombosis during Thoracic Endovascular Aortic Repair in Patient with Protein S Deficiency. ( 25469146 )
2014
17
Multiple and Contemporary Coronary Thrombosis inspite of Low Platelet Function Response. ( 25302230 )
2014
18
Acute myocardial infarction due to coronary thrombosis caused by blunt chest trauma. ( 24769662 )
2014
19
Acute coronary thrombosis and multiple coronary aneurysms in a 22-year-old man with the human immunodeficiency virus. ( 24808786 )
2014
20
Low-Dose Antithrombotic Treatment in Coronary Thrombosis of Kawasaki Disease. ( 25298222 )
2014
21
Coronary thrombosis from large, nonprotruding, superficial calcified coronary plaques. ( 24080108 )
2013
22
Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis. ( 23460076 )
2013
23
Detection of coronary thrombosis after multi-phase postmortem CT-angiography. ( 22981180 )
2013
24
Simultaneous double coronary thrombosis in a 47-year-old male patient with acute myocardial infarction. ( 24175009 )
2013
25
Mechanisms of coronary thrombosis in cigarette smoke exposure. ( 23685556 )
2013
26
Antithrombotic effect of Z4A5 on coronary thrombosis in a canine model of acute unstable angina. ( 23083032 )
2013
27
Varenicline-induced coronary thrombosis. ( 24259623 )
2013
28
Bi-ostial coronary thrombosis due to heparin induced thrombocytopenia. ( 22664366 )
2013
29
Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study. ( 22684577 )
2012
30
Myocardial infarction due to coronary thrombosis in a patient with Henoch-SchAPnlein purpura. ( 22361720 )
2012
31
Acute coronary thrombosis in Boston marathon runners. ( 22236231 )
2012
32
Does sildenafil contribute to acute coronary thrombosis? ( 23363902 )
2012
33
Proteomic profiling of acute coronary thrombosis reveals a local decrease in pigment epithelium-derived factor in acute myocardial infarction. ( 22315956 )
2012
34
Cannabis and coronary thrombosis: What is the role of platelets? ( 21806494 )
2012
35
Diastolic timed Vibro-Percussion at 50 Hz delivered across a chest wall sized meat barrier enhances clot dissolution and remotely administered Streptokinase effectiveness in an in-vitro model of acute coronary thrombosis. ( 23146079 )
2012
36
Calcified nodules: an underrated mechanism of coronary thrombosis? ( 23058076 )
2012
37
Multivessel coronary thrombosis in a patient with idiopathic thrombocytopenic purpura. ( 23304046 )
2012
38
Primary percutaneous coronary intervention and intravascular ultrasound imaging for coronary thrombosis after cisplatin-based chemotherapy. ( 22218740 )
2012
39
Acute coronary thrombosis after anaphylactic shock treatment. ( 22541413 )
2012
40
Coronary thrombosis as the first complication of antiphospholipid syndrome. ( 22735914 )
2012
41
Cocaine-induced coronary thrombosis: what is the optimal treatment strategy. ( 21421194 )
2011
42
Role of platelet glycoprotein receptor IIIa PI(A2) and traditional risk factors in the etiology of coronary thrombosis. ( 21816456 )
2011
43
A study to determine chest wall vibratory attachment interface locations for a low frequency sonic vibrator in treatment of acute coronary thrombosis. ( 21547406 )
2011
44
Coronary thrombosis and myocardial infarction as the initial manifestation of protein C deficiency in a 20-year-old man. ( 21481934 )
2011
45
Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy. ( 21411997 )
2011
46
Prasugrel for the treatment of coronary thrombosis: a review of pharmacological properties, indications for use and future development. ( 21143003 )
2011
47
Right coronary thrombosis in patient supported by Jarvik 2000 left ventricular assist device. ( 21071239 )
2011
48
The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene. ( 21371074 )
2011
49
Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model. ( 20694285 )
2010
50
Acute in-stent coronary thrombosis without ST change on electrocardiography: a case report and literature review. ( 20134386 )
2010

Variations for Coronary Thrombosis

Expression for Coronary Thrombosis

Search GEO for disease gene expression data for Coronary Thrombosis.

Pathways for Coronary Thrombosis

Pathways related to Coronary Thrombosis according to GeneCards Suite gene sharing:

(show all 13)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.69 F3 GP1BA GP6 ITGB3 P2RY12 PLAT
2
Show member pathways
11.88 GP1BA GP6 ITGB3 VWF
3 11.8 F3 PLAT SERPINC1 SERPINE1 VWF
4 11.71 F3 ITGB3 SERPINE1
5 11.64 GP1BA GP6 ITGB3 P2RY12 VWF
6
Show member pathways
11.62 GP1BA ITGB3 VWF
7 11.55 F3 ITGB3 VWF
8
Show member pathways
11.37 F3 GP1BA GP6 PLAT SERPINC1 SERPINE1
9 11.33 GP6 ITGB3 P2RY12 VWF
10 11.21 GP1BA PLAT
11 10.66 GP1BA GP6 VWF
12 10.62 PLAT SERPINE1
13 10.48 GP1BA VWF

GO Terms for Coronary Thrombosis

Cellular components related to Coronary Thrombosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.56 F3 GP1BA GP6 ITGB3 PLAT SERPINC1
2 extracellular matrix GO:0031012 9.46 F3 PLAT SERPINE1 VWF
3 cell surface GO:0009986 9.1 F3 GP1BA GP6 ITGB3 P2RY12 PLAT

Biological processes related to Coronary Thrombosis according to GeneCards Suite gene sharing:

(show all 11)
id Name GO ID Score Top Affiliating Genes
1 extracellular matrix organization GO:0030198 9.67 ITGB3 SERPINE1 VWF
2 platelet degranulation GO:0002576 9.58 ITGB3 SERPINE1 VWF
3 platelet activation GO:0030168 9.55 GP1BA GP6 ITGB3 P2RY12 VWF
4 platelet aggregation GO:0070527 9.5 GP1BA ITGB3 P2RY12
5 regulation of blood coagulation GO:0030193 9.48 GP1BA SERPINC1
6 blood coagulation, intrinsic pathway GO:0007597 9.46 GP1BA VWF
7 cell-substrate adhesion GO:0031589 9.43 ITGB3 VWF
8 fibrinolysis GO:0042730 9.43 GP1BA PLAT SERPINE1
9 hemostasis GO:0007599 9.43 F3 GP1BA GP6 P2RY12 SERPINC1 VWF
10 smooth muscle cell migration GO:0014909 9.37 ITGB3 PLAT
11 blood coagulation GO:0007596 9.23 F3 GP1BA GP6 ITGB3 P2RY12 PLAT

Molecular functions related to Coronary Thrombosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protease binding GO:0002020 9.02 F3 ITGB3 SERPINC1 SERPINE1 VWF

Sources for Coronary Thrombosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....